忘川河
发表于 2025-3-26 23:30:16
http://reply.papertrans.cn/39/3809/380887/380887_31.png
平
发表于 2025-3-27 04:29:48
Funktionelle Grundlagen der Atmung,ressing high-risk features, such as large tumors or tumors with a high mitotic rate, are likely to develop recurrence with distant metastasis. In the past two decades, tyrosine kinase inhibitors were introduced for the treatment of GIST, and imatinib greatly prolonged the survival of metastatic or u
pulmonary-edema
发表于 2025-3-27 08:27:38
https://doi.org/10.1007/978-3-642-91718-9ecular targeted therapy (imatinib, sunitinib, and regorafenib). Developmental therapeutics for GIST is focused on primary or acquired resistance to these agents. In this section, we discuss new agents for the treatment of GIST.
CRANK
发表于 2025-3-27 11:09:50
Depositionsmessungen im Land Brandenburg,GIST is the most frequent mesenchymal tumor in the digestive tract. Imaging modalities comprising of ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT) are routinely used for management of tumor. We focus on diagnosis of staging, recurrence, and monitoring.
HAWK
发表于 2025-3-27 14:29:13
Diagnostic Imaging of Gastrointestinal Stromal Tumor,GIST is the most frequent mesenchymal tumor in the digestive tract. Imaging modalities comprising of ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT) are routinely used for management of tumor. We focus on diagnosis of staging, recurrence, and monitoring.
panorama
发表于 2025-3-27 19:48:42
Yukinori Kurokawa,Yoshito KomatsuEnriches our understanding of GISTs both from basic to clinical aspects.Collects unique and cutting-edge data from the Asian region.Provides a comprehensive update of GISTs
有法律效应
发表于 2025-3-27 23:16:28
http://reply.papertrans.cn/39/3809/380887/380887_37.png
Mercantile
发表于 2025-3-28 06:09:04
New Agents for Gastrointestinal Stromal Tumors,ecular targeted therapy (imatinib, sunitinib, and regorafenib). Developmental therapeutics for GIST is focused on primary or acquired resistance to these agents. In this section, we discuss new agents for the treatment of GIST.
Obstreperous
发表于 2025-3-28 09:55:33
Springer Nature Singapore Pte Ltd. 2019
fastness
发表于 2025-3-28 13:50:43
http://reply.papertrans.cn/39/3809/380887/380887_40.png